Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Ipsen and Marengo Therapeutics Announce Second Strategic Partnership to Advance Precision T-Cell Engager Assets in Marengo's TriSTAR Platform
Friday, June 07, 2024Ipsen and Marengo Therapeutics Inc a clinicalstage biotechnology company today announced the expansion of their current oncology research partnership
InDevR and Sino Biological Team Up to Deliver Multiplexed Analytical Solutions for mRNA Vaccine and Cell & Gene Therapy
Thursday, June 06, 2024InDevR Inc a leader in analytical solutions for vaccine inprocess and quality control testing and Sino Biological Inc a biotechnology company listed
First Participants Vaccinated in IMUNON’s IMNN-101 Phase 1 Clinical Trial
Thursday, June 06, 2024IMUNON Inc a clinicalstage company focused on developing nonviral DNAmediated immunotherapy and evaluating an adaptation of the platforms potential as a nextgeneration vaccine
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608
Thursday, June 06, 2024Relay Therapeutics Inc a clinicalstage precision medicine company transforming the drug discovery process by combining leadingedge computational and experimental technologies
Cellectis Receives Orphan Drug Designation for UCART22, its Allogeneic CAR T Product for Patients with Acute Lymphoblastic Leukemia
Wednesday, June 05, 2024Cellectis a clinicalstage biotechnology company using its pioneering geneediting platform to develop lifesaving cell and gene therapies announced today that the
AGC Biologics Completes Copenhagen Campus Expansion, Doubling Single-use Mammalian Bioreactor Capacity at Site
Wednesday, June 05, 2024Today we announced at BIO International the completion of our new manufacturing building at our Copenhagen campus The completed work doubles our sites singleuse bioreactor capacity for mammalian services
BlueSphere Bio Establishes Strategic Collaboration with the National Cancer Institute to Advance Treatments for Rare Respiratory Disease
Wednesday, June 05, 2024BlueSphere Bio a Tcell receptor Tcell therapy company utilizing a powerful TCR discovery platform to identify novel therapeutic candidates for patients
LadRx and ImmunityBio Mutually Agree to Terminate Aldoxorubicin License
Tuesday, June 04, 2024LadRx Corporation a biopharmaceutical innovator focused on research and development of lifesaving cancer therapeutics is pleased to announce that the Company and NantCell Inc together with NantCells
UniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational Gene Therapy AMT-130 in Huntington’s Disease
Tuesday, June 04, 2024UniQure NV a leading gene therapy company advancing transformative therapies for patients with severe medical needs today announced
FibroGen and Regeneron Collaborate on Clinical Trials for Immuno-Oncology Combination Therapy
Tuesday, June 04, 2024FibroGen Inc today announced a clinical trial supply agreement with Regeneron Pharmaceuticals to evaluate FibroGens immunooncology assets FG and FG in combination with Regenerons antiPD therapy
